Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;39(2):512-515.
doi: 10.1038/s41375-024-02478-2. Epub 2024 Nov 22.

A DNA methylation database of human and mouse hematological malignancy cell lines

Affiliations

A DNA methylation database of human and mouse hematological malignancy cell lines

Aleix Noguera-Castells et al. Leukemia. 2025 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: ME declares past grants from Ferrer International and Incyte and personal fees from Quimatryx, outside the submitted work.

Figures

Fig. 1
Fig. 1. DNA methylation landscape of human and mouse hematological cell lines.
A Schematic representation of hierarchical subdivision of human (top) and mouse (bottom) cell line cohorts based on hematological malignancies. B Heatmap resulting from the unsupervised analysis of the human (left) and mouse (right) hematological cell lines. Dendogram clustering was performed using all methylation values, an 1% of randomly selected CpG probes were used for heatmap visualization. C Phylogenetic analysis of the different hematological subtypes and species. Each leaf represents the 1% most variable CpG sites within each hematologic subtype and specie. The inner circle colors represent if the leaf corresponds to leukemia, lymphoma, multiple myeloma or transformed cell lines, while the outer circle corresponds to the refined classification for human hematological cell lines. D Heatmap resulting from the differential methylation analysis within leukemia, lymphoma and multiple myeloma in human (left) and mouse (right) hematological cell lines. The bottom annotation indicates hematological disease, as described in the heatmap legend. Methylation β-values range from 0 (green) to 1 (red).
Fig. 2
Fig. 2. The DNA methylome of human hematological cell lines can differentiate different hematological malignancies and is associated with drug sensitivity.
A Heatmap resulting from the CpG sites differentially methylated within hematological diseases in human hematological cell lines. The bottom annotation indicates hematological disease, as described in the heatmap legend. Methylation β-values range from 0 (green) to 1 (red). B Heatmap resulting from the CpG sites differentially methylated within hematological diseases in human primary samples. The bottom annotation indicates hematological disease, as described in the heatmap legend. Methylation β-values range from 0 (green) to 1 (red). C Heatmap resulting from the common CpG sites associated with cytarabine, fludarabine and nelarabine drug sensitivity. Top annotation indicates whether the cells are in the sensitive cluster or resistant cluster. The bottom annotation indicates hematological disease and cytarabine, fludarabine and nelarabine sensitivity as described in the heatmap legend. Methylation β-values range from 0 (green) to 1 (red). D Boxplot representing cytarabine (top), fludarabine (middle) and nelarabine (bottom) IC50s of human hematological cell lines grouped according to whether they clustered in sensitive or resistant cluster. Two-sided Mann–Whitney–Wilcoxon test was performed.

References

    1. Scherer WF, Syverton JT, Gey GO. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cell (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med. 1953;97:695. - PMC - PubMed
    1. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603–7. - PMC - PubMed
    1. Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, et al. A Landscape of Pharmacogenomic Interactions in Cancer. Cell. 2016;166:740–54. - PMC - PubMed
    1. Ghandi M, Huang FW, Jané-Valbuena J, Kryukov GV, Lo CC, McDonald ER 3rd, et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019;569:503–8. - PMC - PubMed
    1. Bashi AC, Coker EA, Bulusu KC, Jaaks P, Crafter C, Lightfoot H, et al. Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations. Cancer Discov. 2024;14:846–65. - PMC - PubMed